openPR Logo
Press release

Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market at 5.94% CAGR by 2031

10-18-2024 12:28 AM CET | Associations & Organizations

Press release from: ABNewswire

Peptide Therapeutics Market

Peptide Therapeutics Market

Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of cancer and metabolic disorders such as osteoporosis, obesity and diabetes are expected to increase the use of peptide therapies in the coming years. The number of pediatric patients suffering from these diseases, widespread in low-income areas, need affordable supplies and effective drugs.

The market is expected to grow at a lucrative CAGR during the forecast period as companies focus on developing new drugs. Players have engaged in extensive research and development (R&D) activities to develop targeted therapies and increase their market share. Research and development in peptide therapeutics has focused on metabolism, followed by oncology and infectious diseases. Regulations for peptide therapies are seeing a shift toward more stringent requirements for efficacy, safety, and quality standards for approval. Regulatory agencies such as the FDA and EMA are actively developing new guidelines to refine the approval of peptide therapies.

Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/peptide-therapeutics-market

Business Verticals a Magnified Version of the Competitive Landscape in the Peptide Therapeutics Market

The competitive landscape in the peptide therapeutics market is characterized by interactions between established pharmaceutical giants, biotechnology companies and emerging players each with distinct competitive advantages.

Pharmaceutical Giants: The peptide therapeutics market is dominated by large pharmaceutical companies with huge investments in R&D and a global presence. Companies such as Eli Lilly, Novo Nordisk and Amgen are using their strong financial strength to develop broader peptide-based drugs, especially in areas such as diabetes and oncology.

Innovative research and development: Innovation in drug discovery and technology development is a key driver of competitiveness. Companies are investing heavily in new peptides that can be developed for specific diseases. For example, Eli Lilly's efforts to develop peptide-based drugs for diabetes, such as its breakthrough drug Trulicity, have helped secure a leading position.

For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/peptide-therapeutics-market

Strategic Cooperation and Partnership

November 2022: Anterom developed one of the first immunotherapies based on its bacterial mimicry of drug recognition. Anterom reported safety, immunomodulatory, and efficacy data from its Phase 1/2 clinical trial of EO2401 in combination with an immune checkpoint inhibitor, for the treatment of patients with glioblastoma.

September 2022: Life science group Sartorius, through its French-listed subsidiary Sartorius StedimBiotech, acquired Albumedix Ltd. Albumedix is one of the leaders in recombinant albumin-based solutions.

This report covers following segments:

A. Application

Cancer

Metabolic

Cardiovascular Disorder

Respiratory

Gastrointestinal Diseases (GIT)

Anti-Infection

Pain

Dermatology

Central nervous system (CNS)

Renal

Others

B. Type of Manufacturers

In-house

Outsourced

C. Type

Generic

Innovative

D. Route of Administration

Parenteral

Oral

Pulmonary

Mucosal

Others

E. Synthesis Technology

Solid Phase Peptide Synthesis (SPPS)

Liquid Phase Peptide Synthesis (LPPS)

Hybrid Technology

This report covers the following players:

Amgen, Inc.

AstraZeneca plc

Bachem Holding AG

Bristol-Myers Squibb Company

Eli Lilly and Company

Ipsen S.A.

Merck & Co., Inc.

Novartis AG

Novo Nordisk A/S

Pfizer Inc.

Sanofi S.A.

Takeda Pharmaceutical Company Limited

Teva Pharmaceutical Industries Ltd.

Lonza Group AG

Ferring Pharmaceuticals, Inc.

PolyPeptide Group

Protagonist Therapeutics, Inc.

Ipsen Biopharmaceuticals, Inc.

Polytherapeutics Inc.

Zealand Pharma A/S

Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/peptide-therapeutics-market

Unlocking Future Potential in the Peptide Therapeutics Market

The peptide therapeutics market is poised for significant growth, driven by advances in drug delivery systems, increasing focus on precision medicine, expanding applications in oncology, metabolic disorders and infectious diseases. Peptides offer unique advantages such as high specificity and low toxicity, making them ideal for targeted therapies. With ongoing research, partnerships, and new technologies, the future of peptide therapies promises to deliver new treatments, improve patient outcomes, and be the next generation of medicine.

To read the full report, please visit: https://www.skyquestt.com/report/peptide-therapeutics-market

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=growing-adoption-of-synthetic-peptide-drugs-driving-peptide-therapeutics-market-at-594-cagr-by-2031]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/peptide-therapeutics-market



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market at 5.94% CAGR by 2031 here

News-ID: 3699224 • Views:

More Releases from ABNewswire

My Clothing Store Launches with Eclectic Mix of Fashion, Smart Tech, and Unique Lifestyle Products
My Clothing Store Launches with Eclectic Mix of Fashion, Smart Tech, and Unique …
Washington, DC - My Clothing Store, a new online retail startup, officially launches today offering a carefully curated collection that breaks traditional retail boundaries. The store combines patriotic apparel, smart security technology, premium accessories, and unique lifestyle products in one convenient shopping destination at https://p7ckcz-ma.myshopify.com/. Unlike conventional clothing retailers, My Clothing Store distinguishes itself through an unconventional product mix that includes everything from American-themed apparel and minimalist wallets to smart Bluetooth
My Clothing Store Launches with Eclectic Mix of Fashion, Smart Tech, and Unique Lifestyle Products
My Clothing Store Launches with Eclectic Mix of Fashion, Smart Tech, and Unique …
Washington, DC - My Clothing Store, a new online retail startup, officially launches today offering a carefully curated collection that breaks traditional retail boundaries. The store combines patriotic apparel, smart security technology, premium accessories, and unique lifestyle products in one convenient shopping destination at https://p7ckcz-ma.myshopify.com/. Unlike conventional clothing retailers, My Clothing Store distinguishes itself through an unconventional product mix that includes everything from American-themed apparel and minimalist wallets to smart Bluetooth
Bringing Color to Life: Littleton's Trusted Painting Experts Redefining Home Beauty
Bringing Color to Life: Littleton's Trusted Painting Experts Redefining Home Bea …
Littleton, CO - In today's fast-moving world, homeowners are increasingly turning to trusted professionals to enhance the beauty, comfort, and value of their properties. Among the most transformative upgrades is a high-quality paint job-an investment that not only refreshes a space but also reflects personality and style. Leading the way in this arena, A Perfect Finish Painting has become the name residents trust when searching for reliable painters near me
Reimagining Homes in Littleton: The Artistry of Modern Painting Services
Reimagining Homes in Littleton: The Artistry of Modern Painting Services
Littleton, CO - As homeowners increasingly look to transform their living spaces with elegance and personality, the demand for high-quality painting solutions continues to grow. At the forefront of this transformation, A Perfect Finish Painting is redefining how residents approach interior and exterior upgrades. With a reputation for precision, professionalism, and exceptional customer care, the company has become a top choice for anyone searching for a trusted painting service near

All 5 Releases


More Releases for Peptide

Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
Peptide Vaccine Market Peptide Vaccine Clinical Pipeline Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Peptide Vaccine: A Prologue to Sub-Unit Vaccines 1.1 Introduction 1.2 Glimpse of Antiquity 2. Need of Peptide Vaccines 2.1 Why Peptides – More Desirable 2.2 Peptide Vaccines V/S Traditional Vaccines 3. Classification of Peptide Vaccines 3.1 On the Basis of Sources Obtained 3.2 On the Basis of Length 3.3 On the Basis of